Solésence 10-Q/A Restates Q2 2026: Inventory Cut $157K, Net Loss Widens to $256K
SLSN sits 42% above its 52-week low of $0.613.
Summary
Solésence's amended Q2 2026 10-Q restates inventory down $157 thousand and equity to $12,997 thousand, widens the quarter's net loss to $256 thousand, and confirms two material weaknesses remained at June 30, 2026. It also discloses a $938 thousand Refy Beauty settlement and a lender waiver for inventory-facility over-advances.
Key Events · Corporate Governance and Compliance · SLSN
-
Q2 2026 Restated on Inventory Errors
Inventories at June 30, 2026 fall $157 thousand to $12,800 thousand, and total stockholders' equity drops to $12,997 thousand from $13,154 thousand as previously reported.
-
Quarterly Loss Widens $98K
Cost of revenue rises $98 thousand to $10,682 thousand, pushing the Q2 2026 net loss to $256 thousand from $158 thousand; the six-month loss goes to $1,193 thousand from $1,120 thousand.
-
Two Material Weaknesses Persist
Management concluded disclosure controls and internal control over financial reporting were not effective at June 30, 2026, citing inventory costing and oversight/review of financial reporting and restatement activities.
-
Refy Settlement Adds $938K Liability
A July 6, 2026 settlement with Refy Beauty Ltd for £700,000 ($938 thousand at a fixed $1.34 per pound) was recognized as a June 30, 2026 short-term liability, with a six-month SPF development exclusivity period.
Analysis · SLSN · Industrial Applications And Services
The accounting problem is not a one-off historical fix but an unresolved control failure: this amendment puts hard numbers on the inventory-costing restatement for the June quarter and confirms both material weaknesses persisted at June 30, 2026. The quarter's loss widens to $256 thousand from $158 thousand as originally reported, and equity falls to $12,997 thousand. It also surfaces a $938 thousand Refy Beauty settlement booked into the quarter and a lender waiver covering up to $3,000 per occurrence of inventory-facility over-advances, which tells you the restatement had already pushed the company past a borrowing-base covenant. Against a Nasdaq delisting notice received September 29, 2026, a sub-$1 stock and only $1,046 thousand of cash, the combination of restated books, unremediated controls and related-party-dependent liquidity is the story.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLSN was trading at $0.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $61.5M. The 52-week trading range was $0.61 to $3.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.